EarlyDx Overview
- Year Founded
-
2014
- Status
-
Private
- Employees
-
8
- Latest Deal Type
-
Series A
- Investors
-
8
EarlyDx General Information
Description
Developer of a diagnostic and bioinformatics platform designed for early disease detection and health monitoring purposes. The company's platform integrates sequencing technology and computational methods to analyze genome-wide methylation profiles of cell-free DNA from a single blood sample, features an ultrasensitive library preparation technique, and provides cloud-based bioinformatics tools for data analysis, enabling healthcare providers and diagnostic companies to access affordable, non-invasive, and comprehensive solutions for cancer detection, therapy selection, and treatment monitoring.
Contact Information
Website
www.earlydx.comCorporate Office
- 30601 Agoura Road
- Suite 250, Agoura Hills
- Los Angeles, CA 91301
- United States
Corporate Office
- 30601 Agoura Road
- Suite 250, Agoura Hills
- Los Angeles, CA 91301
- United States
EarlyDx Timeline
EarlyDx Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 10. Later Stage VC (Series A) | 01-Jun-2025 | Completed | Generating Revenue | |||
| 9. Accelerator/Incubator | 01-Jan-2024 | Completed | Generating Revenue | |||
| 8. Later Stage VC (Series A) | 29-Sep-2022 | Cancelled | Generating Revenue | |||
| 7. Seed Round | 01-Dec-2022 | Completed | Generating Revenue | |||
| 6. Grant | 29-Sep-2022 | Completed | Generating Revenue | |||
| 5. Grant | 01-Jun-2020 | Completed | Generating Revenue | |||
| 4. Seed Round | 20-Feb-2020 | Completed | Generating Revenue | |||
| 3. Seed Round | 31-Jan-2018 | Completed | Generating Revenue | |||
| 2. Accelerator/Incubator | Completed | Startup | ||||
| 1. University Spin-Out | 01-Jan-2014 | Completed | Startup |
EarlyDx Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Seed-2 | ||||||||
| Seed-1 | ||||||||
| Seed | 3,200,000 | $0.000100 | $1.9 | $1.9 | 1x | $1.9 | 14.34% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
EarlyDx Patents
EarlyDx Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026222157-A1 | Methods for monitoring transplant outcomes | Pending | 16-Apr-2025 | ||
| EP-4655070-A1 | Methods of hyper- and hypo-methylation analysis for disease detection | Pending | 27-Jan-2023 | ||
| US-20260226553-A1 | Methods of hyper- and hypo-methylation analysis for disease detection | Pending | 27-Jan-2023 | ||
| WO-2024159118-A1 | Methods of hyper- and hypo-methylation analysis for disease detection | Inactive | 27-Jan-2023 | ||
| US-20250092446-A1 | Methods of methylation analysis for disease detection | Pending | 07-Jul-2021 | C12Q1/683 |
EarlyDx Signals
EarlyDx Investors (8)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Device of Tomorrow Capital | Venture Capital | Minority | ||
| Magnify | Accelerator/Incubator | |||
| Westfield BioVentures | Accelerator/Incubator | Minority | ||
| National Cancer Institute | Government | |||
| National Institutes of Health | Government | Minority |
EarlyDx FAQs
-
When was EarlyDx founded?
EarlyDx was founded in 2014.
-
Where is EarlyDx headquartered?
EarlyDx is headquartered in Los Angeles, CA.
-
What is the size of EarlyDx?
EarlyDx has 8 total employees.
-
What industry is EarlyDx in?
EarlyDx’s primary industry is Diagnostic Equipment.
-
Is EarlyDx a private or public company?
EarlyDx is a Private company.
-
What is EarlyDx’s current revenue?
The current revenue for EarlyDx is .
-
How much funding has EarlyDx raised over time?
EarlyDx has raised $14M.
-
Who are EarlyDx’s investors?
Device of Tomorrow Capital, Magnify, Westfield BioVentures, National Cancer Institute, and National Institutes of Health are 5 of 8 investors who have invested in EarlyDx.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process